NIH #T32CA236734
Cell Immunotherapy and Experimental Therapeutics Program (CIETP).
Active
- Amount
- $500K–$600K
- Period
- 2019-07-08 → 2030-06-30
- PIs
- 2
Awarded at UNIVERSITY OF COLORADO DENVER
Antonio Jimeno
Full Professor(heuristic)
Pancreatic and Hepatic Oncology Research · Oncology
Compare more Oncology professors.
h-index49
i10-index107
Publications318
Citations23,500
Grants
6 total · 2 active
NIH #R01DE030683
Targeting oncogenic Myb fusions in salivary gland cancer with the elongation inhibitor SVC112
Active
- Amount
- $400K–$500K
- Period
- 2021-04-01 → 2027-03-31
- PIs
- 1
Awarded at UNIVERSITY OF COLORADO DENVER
NIH #P50CA261605
Colorado Head and Neck Cancer SPORE
- Amount
- $1M–$2M
- Period
- 2021-09-01 → 2026-08-31
- PIs
- 2
Awarded at UNIVERSITY OF COLORADO DENVER
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New paper: Increased accrual of diverse patient populations in oncology phase I clinical trials at the University of Colorado Cancer Center (Frontiers in Oncology)2025-07-15
- New NIH award: Targeting oncogenic Myb fusions in salivary gland cancer with the elongation inhibitor SVC1122021-04-01
- New NIH award: Cell Immunotherapy and Experimental Therapeutics Program (CIETP).2019-07-08
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-09-03
Data may not be current